GSK Posts Higher Q4 Sales, Profits, With Record Sales From Shingles Vaccine
GSK Plc (NYSE:GSK) reported an adjusted fourth-quarter profit of 25.8 pence per share on sales of about £7.4 billion, up 4.2%…
Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off
Novartis AG (NYSE:NVS) has reported Q4 core EPS of $1.52 compared to $1.40 a year ago, beating the consensus of $1.44.…
Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023
Edwards Lifesciences Corp (NYSE:EW) reported Q4 adjusted EPS of $0.64, up 25% Y/Y and higher than the consensus of $0.61.…
Medtronic Recalls Over 22,000 Hemodialysis Catheters For Potential Hub Defect
Medtronic Plc (NYSE:MDT) is recalling around 22,700 hemodialysis catheters due to a possible defect in the device’s hub that…
Caterpillar Set To Report Earnings Tuesday Before The Bell: Here’s What Analysts Are Expecting
Construction and mining equipment manufacturer Caterpillar Inc (NYSE: CAT) is set to report its fourth-quarter earnings on Tuesday before the opening bell, kicking off the earnings season for construction stocks, here’s what investors can expect.
Chinese Stocks, ETFs On Massive Growth Path As Country Reopens After 3 Years Of Zero COVID Policies
It’s been three weeks since Beijing ordered the reopening of China’s borders to the world, and Chinese stocks are rallying.
The world’s second largest economy abruptly ended three years of strict zero-COVID policies late last year, causing a massive spike in COVID cases.
CureVac Shares Pop After Encouraging Update From COVID-19, Flu mRNA Vaccine Programs
CureVac N.V. (NASDAQ:CVAC) announced extended preliminary data from ongoing Phase 1 programs in COVID-19 and seasonal flu conducted in collaboration with GSK…
FDA Gives Conditional Approval For Eli Lilly’s Drug For Rare Blood Cancer
The FDA approved Eli Lilly And Co’s (NYSE:LLY) Jaypirca (pirtobrutinib) for adult patients with relapsed or refractory mantle cell lymphoma (MCL)…
Barron’s Top Weekend Stock Picks: Alibaba, Salesforce, Delta And A Famous Professor Says Tesla Is Overvalued
Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.
Bulls And Bears Of The Week: Tesla, Alphabet, Chevron And Why Trillions Of Shiba Inu Tokens May Be Burned
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.